Global Duodenoscopes Market Size, Share & Trends Analysis Report By Application (Therapeutics/ Treatment and Diagnostics), By Product, By End Use, By Regional Outlook and Forecast, 2025 - 2032

The Global Duodenoscopes Market size is expected to reach $2.29 billion by 2032, rising at a market growth of 5.1% CAGR during the forecast period.

The United States, in particular, has a well-established network of hospitals and endoscopy centers and favorable reimbursement policies that support using duodenoscopes in diagnostic and therapeutic procedures. Furthermore, strong regulatory oversight and continuous efforts to enhance patient safety have spurred demand for reusable and disposable duodenoscope models across the region. Thus, the North America segment recorded 44% revenue share in the market in 2024. This dominance can be attributed to the region’s advanced healthcare infrastructure, high adoption rate of innovative medical technologies, and the increasing prevalence of gastrointestinal disorders.

Minimally invasive endoscopic procedures have become the standard in modern healthcare, driving the demand for duodenoscopes. These procedures offer many advantages over traditional surgical approaches, including reduced recovery times, minimal scarring, and a lower risk of complications. Duodenoscopes, which are essential for procedures such as endoscopic retrograde cholangiopancreatography (ERCP), play a critical role in enabling physicians to access and treat the duodenum, bile ducts, and pancreas without the need for large incisions. In conclusion, the growing preference for minimally invasive endoscopic procedures drives the market's growth.

Additionally, the expansion of healthcare infrastructure is a pivotal driver of the market. As healthcare systems worldwide continue to grow and evolve, more hospitals, clinics, and specialized healthcare centers are equipped with advanced endoscopic tools, including duodenoscopes. In both developed and emerging economies, governments and private sectors are investing heavily in upgrading healthcare facilities, increasing their capacity to deliver high-quality endoscopic services. Expanded access to modern medical technologies enables more healthcare professionals to incorporate duodenoscopes into their diagnostic and therapeutic practices. Thus, as healthcare systems continue to evolve and expand, the demand for duodenoscopes will inevitably grow, contributing to global market expansion.

The COVID-19 pandemic significantly disrupted the market. As hospitals and healthcare facilities shifted their focus toward managing the overwhelming number of COVID-19 cases, elective procedures, including many endoscopic examinations, were postponed or cancelled. This led to a sharp decline in the demand for duodenoscopes, which are primarily used in gastrointestinal diagnostic and therapeutic procedures. Thus, the COVID-19 pandemic had a negative impact on the market.

However, one of the key restraints limiting the growth of the market is the high cost and logistical challenges associated with single-use duodenoscopes. While single-use duodenoscopes have been introduced to reduce the risk of cross-contamination and infection, they come with a significant price tag. The cost per unit of a single-use duodenoscope is considerably higher than reusable models, making it a more expensive option for hospitals and healthcare systems, particularly in cost-sensitive regions. For many healthcare providers, especially those in emerging markets or smaller healthcare facilities, the high expense of single-use duodenoscopes poses a financial burden that could lead to reduced adoption. Therefore, this economic barrier could hinder the adoption of single-use duodenoscopes, impacting the overall growth of the duodenoscope market in certain regions.

Product Outlook

Based on product, the market is characterized into reusable and disposable. The disposable segment procured 15% revenue share in the market in 2024. The demand for disposable duodenoscopes has risen as healthcare institutions focus more on infection control and reducing cross-contamination risks. Single-use devices eliminate the need for complex reprocessing and minimize the chances of patient-to-patient transmission of pathogens.

Reusable Outlook

The reusable segment is further subdivided into flexile and rigid. The rigid segment held 9% revenue share in the market in 2024. Although less commonly used than flexible scopes, rigid duodenoscopes remain relevant in specific clinical scenarios where straight access is sufficient, and flexibility is not a primary requirement. These scopes are known for their structural stability and durability, which can be beneficial in certain diagnostic procedures.

Application Outlook

On the basis of application, the market is classified into diagnostics and therapeutics/ treatment. The therapeutics/ treatment segment recorded 68% revenue share in the market in 2024. These instruments are vital in various therapeutic interventions, including bile duct stent placements, stone extractions, and sphincterotomies. As endoscopic procedures continue to evolve, the use of duodenoscopes in therapeutic applications has expanded, especially in managing complex pancreatic and biliary diseases.

End Use Outlook

By end use, the market is divided into hospitals and outpatient facilities. The outpatient facilities segment garnered 53% revenue share in the market in 2024. These centers are increasingly preferred for less invasive and routine endoscopic procedures due to their cost-effectiveness, shorter wait times, and quicker patient turnaround. Advances in duodenoscope technology and the growing trend of shifting procedures from inpatient to outpatient settings have made it feasible for these facilities to offer high-quality care.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment witnessed 30% revenue share in the market in 2024. The region benefits from a growing elderly population, rising incidence of digestive disorders, and increasing investment in endoscopic technologies. European countries emphasize minimally invasive diagnostic and treatment techniques, which support using duodenoscopes across healthcare settings.

List of Key Companies Profiled

• Olympus Corporation
• Ambu A/S
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• SonoScape Medical Corp.
• Karl Storz SE & Co. KG
• Hoya Corporation
• Medtronic PLC
• EndoMed Systems GmbH
• Smart Medical Systems Ltd.

Global Duodenoscopes Market Report Segmentation

By Application

• Therapeutics/ Treatment
• Diagnostics

By Product

• Reusable

Flexile

Rigid

• Disposable

By End Use

• Outpatient Facilities
• Hospitals

By Geography

• North America

US

Canada

Mexico

Rest of North America

• Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

• Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

• LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA